Peer-reviewedCC BY 4.0Frontiers in Immunology
Protein pyruvylation: a potential metabolic checkpoint in tumor immunity?
5 affiliations
- 1Zhejiang Chinese Medical University
- 2Affiliated Xiaoshan Hospital, Hangzhou Normal University
- 3The Xiaoshan Affiliated Hospital of Wenzhou Medical University, The First People’s Hospital of Xiaoshan District Hangzhou
- 4Department of General Surgery, Nanyang Street Community Health Service Center
- 5Department of Tumor Surgery, The Second Affiliated Hospital of Bengbu Medical University
Related
- VISTA as a tumour-microenvironment checkpoint: spatial, metabolic and cellular control of antitumour immunity
- Antitumor immunity and immune-related toxicity during immune checkpoint inhibition: mechanistic overlap, tissue selectivity, and interventional evidence
- Dense Longitudinal Multi Omics Reveals Microbial Metabolic Immune Succession During Immune Checkpoint Therapy
- PTPRF is a stress responsive cytoskeletal checkpoint that coordinates metabolic adaptation in hepatocytes and β cells
- A stromal metabolic program suppresses NK-cell immunity to drive tumor progression in HER2-low breast cancer
BibTeX
@article{liu2026protein,
title = {{Protein pyruvylation: a potential metabolic checkpoint in tumor immunity?}},
author = {Ren Liu and Jiamin Yuan and Haigang Jin and Lida Ge and Chunxia Dai and Wei Wang and Pengping Li and Zhenyu Wang},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1827786},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1827786/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Protein pyruvylation: a potential metabolic checkpoint in tumor immunity?
AU - Ren Liu
AU - Jiamin Yuan
AU - Haigang Jin
AU - Lida Ge
AU - Chunxia Dai
AU - Wei Wang
AU - Pengping Li
AU - Zhenyu Wang
PY - 2026
DA - 2026/10/19
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1827786
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1827786/full
SN - 1664-3224
ER -